VTE Diagnosis and Exclusion Pathway

Wells, PERC and the age-adjusted D-dimer in sequence, and where that leaves you · v1.8

  • Enter the clinical findings in the order asked. The tool holds the sequence: clinical probability first, then the PERC rule where the probability is genuinely low, then an age-adjusted or YEARS D-dimer.
  • Enter the age first. The PERC age criterion and the age-adjusted D-dimer are both derived from it.
  • Select the DVT pathway and the leg findings replace the chest ones.
  • You get the point at which venous thromboembolism is excluded, or the imaging that is now indicated.

  • Children and adolescents under 18. Wells, PERC and YEARS were derived in adults, and the pretest probabilities they rest on do not hold in a child.
  • Pregnancy and the first 6 weeks after delivery, where the page hands over to the pathway written for suspected VTE in pregnancy.
  • A confirmed clot. This is a rule-out pathway: it does not stage a pulmonary embolism and it does not set the anticoagulation.

1. Target Pathology

2. Demographics & Vitals

3. Clinical Vitals

4. Clinical History

5. Presenting Symptoms & Gestalt

Academic Pearls & Pathophysiology

1. Clinical Context: Avoiding Financial & Renal Toxicity

The defensive reflex: In a crowded Indian ED or OPD, a D-Dimer and then a CTPA get ordered defensively for almost any chest pain or dyspnoea. The patient pays for both out of pocket, and takes the radiation and the risk of contrast-induced nephropathy with them. The PERC rule exists to halt this cascade. Where the clinician's own judgement already puts the probability low and PERC is negative, a D-dimer answers nothing: a positive result then commits you to the imaging you had already decided this patient did not need. PERC was derived and validated only in that low-probability group, so it is not a way of clearing a patient in whom PE is the most likely diagnosis.

2. Mnemonic: PERC Rule-Out Criteria

Use the HAD CLOTS mnemonic to remember the 8 variables that must be absent to rule out PE without a D-dimer:

Hormone use (Oestrogen)
Age ≥ 50
DVT or PE history

Coughing blood (Haemoptysis)
Leg swelling (Unilateral)
O₂ Saturation < 95%
Tachycardia (HR ≥ 100)
Surgery or Trauma (Recent)

3. Pathophysiology: Age-Adjusted D-Dimer

Why the cut-off moves with age: D-Dimer is a degradation product of cross-linked fibrin. Baseline coagulation activation and low-grade systemic inflammation both rise with age, so a healthy 75-year-old sits higher on the same assay than a healthy 30-year-old does. Hold them both to 500 ng/mL and the older patient tests positive for being old. Age-adjustment (Age × 10) restores the specificity of the test without sacrificing safety.

4. Illness Scripts: Chest Pain / Dyspnoea

Pulmonary Embolism (PE)
Presentation: Sudden onset pleuritic chest pain, unexplained tachycardia out of proportion to fever, clear lungs on auscultation, hypoxaemia.
Discriminator: Presence of unilateral leg swelling or recent immobilisation.
Acute Coronary Syndrome (ACS)
Presentation: Crushing, retrosternal pressure radiating to jaw/arm, diaphoresis, nausea.
Discriminator: Pain is usually non-pleuritic. ECG changes (ST elevation/depression).
Lobar Pneumonia
Presentation: Gradual onset, productive cough, high-grade fever with chills.
Discriminator: Focal crackles/bronchial breath sounds on auscultation. Elevated procalcitonin.
Abbreviations: ACS (Acute Coronary Syndrome) · CT (Computed Tomography) · CTPA (Computed Tomography Pulmonary Angiography) · DDU (D-Dimer Units) · DVT (Deep Vein Thrombosis) · ECG (Electrocardiogram) · ED (Emergency Department) · FEU (Fibrinogen Equivalent Units) · HR (Heart Rate) · HRT (Hormone Replacement Therapy) · LMWH (Low Molecular Weight Heparin) · O₂ (Oxygen) · OCP (Oral Contraceptive Pill) · OPD (Outpatient Department) · PE (Pulmonary Embolism) · PERC (Pulmonary Embolism Rule-out Criteria) · SaO₂ (Arterial Oxygen Saturation) · VTE (Venous Thromboembolism)
References
  1. Wells PS, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging. Ann Intern Med. 2001;135(2):98-107.
  2. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003;349(13):1227-1235.
  3. Kline JA, Nelson RD, Jackson RE, Courtney DM. Criteria for the safe use of D-dimer testing in emergency department patients with suspected pulmonary embolism: a multicenter US study. Ann Emerg Med. 2002;39(2):144-152.
  4. Kline JA, Mitchell AM, Kabrhel C, Richman PB, Courtney DM. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost. 2004;2(8):1247-1255.
  5. Kline JA, et al. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost. 2008;6(5):772-780.
  6. Righini M, Van Es J, Den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA. 2014;311(11):1117-1124.
  7. Le Gal G, Robert-Ebadi H, Thiruganasambandamoorthy V, et al. Age-adjusted D-dimer cutoff levels to rule out deep vein thrombosis. JAMA. 2026;335(5):416-424.
  8. van der Hulle T, et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study). Lancet. 2017;390(10091):289-297.
  9. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism, developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603.
  10. Giri J, Bhatt DL, Barnes GD, et al. 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults. Circulation / J Am Coll Cardiol. 2026. Published 20 February 2026.
  11. Indian College of Cardiology / Association of Physicians of India (API). National Consensus on Management of Venous Thromboembolism. J Assoc Physicians India. 2018.
How to Cite This Tool

DOIhttps://doi.org/10.5281/zenodo.22401665

AMA Style:Umakanth S. VTE Diagnosis and Exclusion Pathway. Version 1.8. MEDiscuss Clinical Decision Support System. Published 2026. Accessed . https://mediscuss.org/cdss/vte-exclusion. doi:10.5281/zenodo.22401665

Vancouver Style:Umakanth S. VTE Diagnosis and Exclusion Pathway [Internet]. Version 1.8. MEDiscuss.org; 2026 [cited ]. Available from: https://mediscuss.org/cdss/vte-exclusion. doi:10.5281/zenodo.22401665

Disclaimer and scope
Disclaimer: This decision-support system is written for healthcare professionals. It does not substitute clinical judgment, and the treating physician retains absolute responsibility for every diagnostic, dosing and therapeutic decision. The algorithms are built on the evidence as it stands, and the evidence moves. Verify the output against your current institutional protocol, and against the patient in front of you.
© 2026 MEDiscuss.org. All rights reserved. Provided free of charge for clinical use. Unauthorised reproduction or redistribution is strictly prohibited.
Category Risk Scores & Diagnostic PathwaysPathway
Specialties Internal Medicine, Cardiology

Written and maintained by

Dr Shashikiran Umakanth

Last revised 24 August 2026

How these tools are written and reviewed

Related Clinical Tools
Pregnancy VTE ExclusionVKA / Warfarin TitrationPre-Surgical Risk Pathway